11 completed, 1 unknown. 12 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Completed 11, Unknown 1 |
Follow Haemophilus Influenzae Type b: new trials by email Literature Review of Haemophilus Influenzae Type b trials Research Report on Haemophilus Influenzae Type b
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery Infanrix hexa - Diphtheria, Hepatitis B | Phase 4 | Completed | GlaxoSmithKline | 551 | 2016-09-19 | 2020-01-14 |
| Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ Blood Sampling - Tetanus, Poliomyelitis | Phase 4 | Completed | GlaxoSmithKline | 58 | 2011-05-30 | 2021-01-19 |
| Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine Shan 5 - Diphtheria, Tetanus | Phase 4 | Unknown | Shantha Biotechnics Limited | 3000 | 2009-01-01 | 2009-05-06 |
| Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants Infanrix™ hexa - Hepatitis B, Tetanus | Phase 4 | Completed | GlaxoSmithKline | 224 | 2008-09-23 | 2019-11-27 |
| Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine Shan5 - Diphtheria, Tetanus | Phase 4 | Completed | Shantha Biotechnics Limited | 160 | 2008-03-01 | 2009-06-25 |
| Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine Shan 5, Easy Five - Diphtheria, Tetanus | Phase 4 | Completed | Shantha Biotechnics Limited | 144 | 2008-03-01 | 2009-06-25 |
| Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine Menitorix, Infanrix IPV - Haemophilus Influenzae Type b, Neisseria Meningitidis | Phase 4 | Completed | GlaxoSmithKline | 288 | 2007-05-16 | 2020-06-16 |
| Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants GSK Biologicals' combined DTPa-IPV/Hib vaccine - Diphtheria, Tetanus | Phase 4 | Completed | GlaxoSmithKline | 2590 | 2004-11-02 | 2020-01-02 |
| Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines Diphteria, Tetanus, Polio, Acellular Pertussis, Hib vaccine - Diphtheria, Tetanus | Phase 4 | Completed | Sanofi | 387 | 2003-10-01 | 2012-04-16 |
| Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course DTPa-HBV-IPV/Hib Vaccine (INFANRIX™ HEXA), DTPa-HBV-IPV-Hib vaccine (HEXAVAC™) - Hepatitis B, Poliomyelitis | Phase 4 | Completed | GlaxoSmithKline | 494 | 2003-10-01 | 2016-08-05 |
| The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine Hib conjugate vaccine - Haemophilus Influenzae Type b | Phase 4 | Completed | Public Health England | 2003-04-01 | 2018-08-24 | |
| Study to Eliminate Hib Carriage in Rural Alaska Native Villages Hib conjugate vaccine (HbOC, Wyeth Vaccines) - Haemophilus Influenzae Type B, Carrier State | Phase 4 | Completed | Centers for Disease Control and Prevention | 3200 | 2001-09-01 | 2005-09-12 |
Haemophilus Infections (12) · Diphtheria (9) · Tetanus (9) · Hepatitis B (7) · Poliomyelitis (6) · Whooping Cough (5)
Bacterial Infections (12) · Bacterial Infections and Mycoses (12) · Gram-Negative Bacterial Infections (12) · Infections (12) · Pasteurellaceae Infections (12) · Actinomycetales Infections (9) · Clostridium Infections (9) · Corynebacterium Infections (9) · Gram-Positive Bacterial Infections (9) · Virus Diseases (9) · Blood-Borne Infections (7) · Communicable Diseases (7) · DNA Virus Infections (7) · Digestive System Diseases (7) · Hepadnaviridae Infections (7)
Blood Specimen Collection (1) · Hexavac (1) · HibTITER protein, Haemophilus influenzae (1) · Pentavac (1) · Tetanus Toxoid (1) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (1)
GlaxoSmithKline (6) · Shantha Biotechnics Limited (3) · Centers for Disease Control and Prevention (1) · Public Health England (1) · Sanofi (1)
India (3) · Canada (2) · Finland (2) · Italy (2) · Sweden (2) · Australia (1) · Czechia (1) · Norway (1) · Philippines (1) · Poland (1) · Singapore (1) · Spain (1) · United Kingdom (1) · United States (1)
Raman Rao, MD (3) · Elizabeth Miller, MBBS FRCPath (1) · Thomas W Hennessy, MD,MPH (1)
2014 (1), 2015 (1)